Related Experiment Videos
Intravenous drug abuse causes Rh immunization.
J Bowman1, C Harman, F Manning
1Department of Pediatrics and Child Health, University of Manitoba and Health Sciences Centre, Winnipeg, Canada.
Vox Sanguinis
|January 1, 1991
Summary
Intravenous drug use can lead to Rh immunization in Rh-negative women through blood sharing. This can cause severe hemolytic disease and hydrops fetalis in fetuses, resulting in significant reproductive damage.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Public Health
Background:
- Intravenous drug abuse is a significant public health issue with various associated health risks.
- Rh immunization in pregnancy poses risks to fetal well-being.
- Sharing needles and blood can transmit infectious agents and antigens.
Observation:
- A study observed 27 Rh-negative women (28 pregnancies) with a history of intravenous drug abuse.
- Four women (5 pregnancies) developed Rh immunization due to sharing blood with Rh-positive partners.
- Severe hydrops fetalis was noted in 4 out of 5 affected fetuses.
Findings:
- The severity of fetal hemolytic disease was extreme, with only one surviving infant showing neurological damage.
- Continuous exposure to Rh(D) antigen through blood sharing likely contributed to the severity.
- One fetus required intravascular transfusions, and another pregnancy resulted in spontaneous abortion.
Implications:
- This highlights a critical risk associated with intravenous drug abuse and blood sharing.
- Early identification and intervention are crucial for managing Rh immunization in high-risk pregnancies.
- Preventive strategies targeting intravenous drug users are essential to reduce adverse reproductive outcomes.